Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The FDA has announced that it had published a list of off-patent, off-exclusivity branded drugs with approved and generics and had also enacted a new...
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to expand the indication of Novo Nordisk’s diabetes...
The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the European market, as Sanofi and...
Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and Erelzi (...
UK patients will be given access to Santhera Pharmaceutical’s Duchene Muscular Dystrophy drug, Raxone (idebenone), through the Early Access to...
Featuring an exclusive NHS interview on the recent cyber attack and the full story on the new Brexit Health Alliance, as well as features on patient...
A position opinion from the EMA for Samsung Bioepis’ biosimilar of Humira looks set to unleash a second rival to the best-selling drug, after Amgen...
Roche has revealed new data on its investigational haemophilia therapy ACE910 (emicizumab) which shows an 87% reduction in bleed rate among...
The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with the NHS is...
Novo Nordisk is hopeful about the prospects of its diabetes drug semaglutide as a treatment for obesity after it produced positive results in a...